ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Antibe Therapeutics Inc

Antibe Therapeutics Inc (ATE)

0.405
0.00
( 0.00% )
Actualizado: 18:00:00

Herramientas de nivel profesional para inversores individuales.

ATE Noticias

Solo noticias oficiales

ATE Discussion

Ver más
kahlua kahlua 1 año hace
Well the tablet re-formulation ended up being very costly from both a time and money perspective, so this pivot/re-formulation really better pay off with stellar p2 results. Hopefully we get the readout data prior to the end of Q2 2024. I still see this as a strong risk/reward setup, it’s just been the opportunity cost of having tied up the funds. Interest in the share price should pick up heading into Q1.
👍️0
kahlua kahlua 2 años hace
This board is a ghost town.

My take on thecurrent situation with Antibe:

With a current $25M CAD m/c I think the risk/reward setup here is about 20% risk for 300%+ reward leading up to the phase 2 acute otena readout by late 2023. Worthy of a on of due diligence since there’s been a lot of costlyhiccups with this company but the shares are currently trading as though none of the underlying fundamentals matter at all.

The company has more than enough cash to fund the ph2 trial. They have pivoted from chronic to the acute pain market which, while smaller annual peak sales, offers a far more de-risked pathway to positive ph2 readout results and inevitable commercialization/buyout post ph3. The IP reformulation also demonstrably helps de-risk the results with a more rapid onset and significantly reduced dosing regime. This could enable them, once funds allow, to go back to chronic otena for a ph3. But the sweet spot is here and now for those with funds and about one year of patience.

What I’ve learned with biotechs is know your company very well but as important, know the cycle of when time and money are on your side or when they’re against you. All in my opinion.
👍️0
treedoc treedoc 3 años hace

https://m.canadianinsider.com/node/7?ticker=ATE&fbclid=IwAR3q4E-W8ZRcSlyhCwwamdTOLXDHInLgVBGQMvuMDbrVj6Vy21eyzl-sN3M
👍️0
treedoc treedoc 3 años hace

https://www.biospace.com/article/releases/antibe-therapeutics-provides-clinical-update-for-otenaproxesul/
👍️0
treedoc treedoc 3 años hace
Received proxy material
👍️0
treedoc treedoc 3 años hace
https://www.lelezard.com/en/news-19876628.html
👍️0
RoadShowPartner RoadShowPartner 3 años hace
**Attention Accredited Investor and Shareholders**
Please feel free to tune in to hear directly from management in an exclusive Zoom presentation for accredited investors and shareholders. Company executives will be giving an overview of the story while discussing upcoming catalysts and answering live questions. Register using the link below:

https://www.eventbrite.com/e/antibe-therapeutics-inc-webinar-6222021-registration-159355880729?ref=enivtefor001&invite=MjA1MDk0NjcvZ3RvZGRtYXJrZXlAZ21haWwuY29tLzA%3D%0A&utm_source=eb_email&utm_medium=email&utm_campaign=inviteformalv2&utm_term=eventpage
👍️0
treedoc treedoc 4 años hace
FDA clearance a bit dated but opens up US for stage 3 trials. Pretty sweet imo.

Antibe Therapeutics Receives FDA Clearance of IND Application for Otenaproxesul for Osteoarthritis Pain http://ca.finance.yahoo.com/news/antibe-therapeutics-receives-fda-clearance-110000132.html?soc_src=community&soc_trk=ma
👍️0
treedoc treedoc 4 años hace
Flying low under the USA radar.

https://antibethera.com/
👍️0
treedoc treedoc 4 años hace
I’m pretty sure not many have looked into the potential this one has.
Long and IMO of coarse.
👍️0
Mindoro99 Mindoro99 4 años hace
Yeah, baby!
👍️0
treedoc treedoc 4 años hace
$5 US. That’s pretty.
👍️0
Amatuer17 Amatuer17 4 años hace
After a long time - company found a partner and some funding.
Hopefully now they can move forward and give good results.
The product is good and has big potential in US
👍️0
Mindoro99 Mindoro99 4 años hace
Excellent news, kudos to Dan and his team on this. More partnerships to come. Load up at these levels, still way undervalued!
👍️0
treedoc treedoc 4 años hace

https://finance.yahoo.com/news/antibe-therapeutics-announces-strategic-licensing-120000925.html
👍️0
dubt dubt 4 años hace
Ring the bell at tsx. Amazing what some exposure can do
👍️0
Renee Renee 4 años hace
ATBPF one for 10 reverse split. **PPS closed at .30

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
👍️0
dubt dubt 4 años hace
Not great seemingly
👍️0
dubt dubt 4 años hace
See how the Canadian up listing will treat the stock. Positive so far with announcement
👍️0
DirtyPenny DirtyPenny 4 años hace
386,782,798 added another million plus to the o/s
👍️0
Ecomike Ecomike 4 años hace
Interesting biotech that has almost no volume, compared to similar ones, maybe the volume is north of the border?

The Drug and potential is very interesting. On my radar now.

Will major news and whole lot volume to break and run big time.

And time line on the Phase III trial?
👍️0
DirtyPenny DirtyPenny 4 años hace
more added, outstanding now 385,516,301
they added +100 million shares since last year.
👍️0
janeyH janeyH 4 años hace
continues to be shit on
👍️0
DirtyPenny DirtyPenny 4 años hace
added 19 million shares since 3/30, is this another dilution pos
👍️0
janeyH janeyH 4 años hace
continues to be shit on
👍️0
treedoc treedoc 4 años hace
Halt!
👍️0
Amatuer17 Amatuer17 4 años hace
Heard the cc and Q&A

They were all very positive - all plan for next steps.

The phase 2/3 is good but with 12 week trial with 300+ patients and split into 2 phases - I think it is a long road and funding may be an issue.
👍️0
dubt dubt 4 años hace
Yeah, not sure if people were just expecting a blow up instantly, but with the current MC to the potential I think we should see some real growth and pops at in partnership and other milestone. This is a multi dollar stock.
👍️0
janeyH janeyH 4 años hace
wow, but continued doo-doo-ing in the stock - big volume
👍️0
dubt dubt 4 años hace
Everything positive from the CC. lots of details, i believe they will put the transcript up on the website. Timelines haven't changed. everything moving forward as planned on better than expected results.
👍️0
janeyH janeyH 4 años hace
great - pls let us know what you think
👍️0
dubt dubt 4 años hace
I’m on it
👍️0
janeyH janeyH 4 años hace
can’t make it - can anyone else?
👍️0
dubt dubt 4 años hace
Conference call June 4
👍️0
janeyH janeyH 4 años hace
Especially given the volume here two days of very heavy downward volume
👍️0
Amatuer17 Amatuer17 4 años hace
Agree - I cannot see any update from company or someone on why such a bad reaction.
I thought the results were good
👍️0
janeyH janeyH 4 años hace
i am surprised by the degree of the sell off here
👍️0
waltd waltd 4 años hace
I sold 30k at .45 and got out, should have sold friday, better not complain as douled money and dont like the action, good news and fall ? im moving on!
👍️0
DirtyPenny DirtyPenny 4 años hace
happens often, investors buy the rumor/speculation, then sell the news.
good luck
👍️0
Mogles Mogles 4 años hace
The market is failing to price these results into the share price. Wasn’t expecting shares to go down on positive news. What was the market expecting here, FDA approval. Any guesses as to stock performance? This company is very undervalued for its stage of development and product pipeline.
👍️0
treedoc treedoc 4 años hace
Very good news Amatuer17.
👍️0
Amatuer17 Amatuer17 4 años hace
Results out - they look very good as expected.

All 3 doses showed very good results and top 2 doses showed statistical significance . New registrational pivotal P2/3 trial being planned.


https://finance.yahoo.com/news/antibe-therapeutics-announces-positive-top-103000987.html
👍️0
NotTheFace1337 NotTheFace1337 4 años hace
Woot! Ty!
👍️0
djmurdock djmurdock 4 años hace
https://www.bnnbloomberg.ca/video/robert-mcwhirter-discusses-antibe-therapeutics~1968070
👍️0
NotTheFace1337 NotTheFace1337 4 años hace
So what I miss lol?
👍️0
djmurdock djmurdock 5 años hace
https://www.facebook.com/watch/?v=365342554408162
👍️0
djmurdock djmurdock 5 años hace
I expected a delay, just not that much. I have a feeling it will be 2-3 weeks and they wanted to be safe give themselves a buffer zone.
👍️0
Mogles Mogles 5 años hace
Great hire in Dr Stauffer as Chief Medical Officer. Shows management’s confidence in P2b.
👍️0
Mindoro99 Mindoro99 5 años hace
Another 6 weeks, apparently.....
👍️0
Amatuer17 Amatuer17 5 años hace
6 more weeks - well at least they have all the data and no impact on trial parameters.


https://finance.yahoo.com/news/antibe-therapeutics-updates-timing-top-103000962.html
👍️0

Su Consulta Reciente

Delayed Upgrade Clock